1. Home
  2. COLL vs EVEX Comparison

COLL vs EVEX Comparison

Compare COLL & EVEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$45.76

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Eve Holding Inc.

EVEX

Eve Holding Inc.

HOLD

Current Price

$3.03

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
COLL
EVEX
Founded
2002
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Aerospace
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
COLL
EVEX
Price
$45.76
$3.03
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
5
Target Price
$51.17
$6.88
AVG Volume (30 Days)
406.2K
1.2M
Earning Date
02-26-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.63
N/A
Revenue
$757,067,000.00
N/A
Revenue This Year
$26.17
N/A
Revenue Next Year
$3.65
N/A
P/E Ratio
$28.17
N/A
Revenue Growth
26.34
N/A
52 Week Low
$23.23
$2.83
52 Week High
$50.79
$7.70

Technical Indicators

Market Signals
Indicator
COLL
EVEX
Relative Strength Index (RSI) 46.77 23.01
Support Level $43.99 $3.21
Resistance Level $49.31 $3.88
Average True Range (ATR) 1.62 0.22
MACD -0.12 -0.09
Stochastic Oscillator 38.19 1.57

Price Performance

Historical Comparison
COLL
EVEX

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

About EVEX Eve Holding Inc.

Eve Holding Inc is a provider of Urban Air Mobility solutions. The company's operating segments are; eVTOL that includes; the design and production of electric vertical take-off and landing vehicles (eVTOLs) including fixed wing and helicopter operators, as well as lessors that purchase and manage aircraft on behalf of operators; Service and Operations Solutions segment which includes a portfolio of maintenance and support services focused on its and third-party eVTOLs; and the UATM segment , a new Urban Air Traffic Management system designed to allow eVTOLs to operate safely and efficiently in dense urban airspace alongside conventional aircraft and drones.

Share on Social Networks: